文献速递慢性肾脏病

大型整合医疗系统中异常估计肾小球滤过率结果的随访:混合方法研究

Follow-up of Abnormal Estimated GFR Results Within a Large Integrated Health Care Delivery System: A Mixed-Methods Study.
PubMed 文献 · Am J Kidney Dis · 2019-07-16

该混合方法研究在大型整合医疗系统中分析244,540例成人异常eGFR结果的及时随访情况,发现58%患者存在随访缺口。电子病历中异常肌酐标记与更好随访相关(RR 0.65,95%CI 0.64-0.66)。医生访谈揭示系统层面和提供者层面因素影响实验室结果管理。

要点

  • 58%患者异常eGFR结果缺乏及时随访。
  • 电子病历异常肌酐标记与随访改善相关(RR 0.65)。
  • 医生消息框管理滞后和面板规模影响随访。

核心结论

  • 在基于电子病历的整合医疗系统中,异常eGFR结果的及时随访仍具挑战性。
  • 改善提供者消息框管理、利用健康信息技术标记异常结果、调整组织人员配置及提升患者参与可能改善随访。

研究设计与样本

  • 混合方法研究:回顾性电子健康记录分析和医生访谈。
  • 定性分析纳入15名医生访谈。

主要发现

  • 58%患者缺乏及时随访(存在照护缺口)。
  • 电子病历中异常肌酐结果标记与更好随访相关(RR 0.65;95% CI,0.64-0.66)。
  • 患者在线门户使用和医生面板规模与随访弱相关。
  • 提供者电子病历消息框管理滞后与更高照护缺口风险相关。
  • 医生访谈识别出系统层面(如面板规模、实验室结果管理协助)和提供者层面(如电子病历工具熟练度)因素影响实验室结果管理。

关键数值与推荐

  • 及时随访定义:60至150天内重复eGFR,或60天前随访检测显示肾功能正常,或60天前诊断慢性肾脏病或肾癌。

临床怎么用

  • 临床可考虑在电子病历中标记异常eGFR结果以促进随访。
  • 优化提供者消息框管理、增加护士在实验室结果管理中的角色可能减少照护缺口。
  • 提升患者门户参与度可能改善检测随访。

局限性

  • 无法捕捉有意的随访检测延迟。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Timely follow-up of abnormal laboratory results is important for high-quality care. We sought to identify risk factors, facilitators, and barriers to timely follow-up of an abnormal estimated glomerular filtration rate (eGFR) for the diagnosis of chronic kidney disease. STUDY DESIGN: Mixed-methods study: retrospective electronic health record (EHR) analyses, physician interviews. SETTING & PARTICIPANTS: Large integrated health care delivery system. Quantitative analyses included 244,540 patients 21 years or older with incident abnormal eGFRs from January 1, 2010, to December 31, 2015, ordered by 7,164 providers. Qualitative analyses included 15 physician interviews. EXPOSURES: Patient-, physician-, and system-level factors. OUTCOME: Timely follow-up of incident abnormal eGFRs, defined as repeat eGFR obtained within 60 to 150 days, follow-up testing before 60 days that indicated normal kidney function, or diagnosis before 60 days of chronic kidney disease or kidney cancer. ANALYTICAL APPROACH: Multivariable robust Poisson regression models accounting for clustering within provider were used to estimate risk ratios (RRs) and 95% CIs for lack of timely follow-up. Team coding was used to identify themes from physician interviews. RESULTS: 58% of patients lacked timely follow-up of their incident abnormal eGFRs (ie, had a care gap). An abnormal creatinine result flag in the EHR was associated with better follow-up (RR for care gap, 0.65; 95% CI, 0.64-0.66). Patient online portal use and physician panel size were weakly associated with follow-up. Patients seen by providers behind on managing their EHR message box were at higher risk for care gaps. Physician interviews identified system-level (eg, panel size and assistance in managing laboratory results) and provider-level (eg, proficiency using EHR tools) factors that influence laboratory result management. LIMITATIONS: Unable to capture intentional delays in follow-up testing. CONCLUSIONS: Timely follow-up of abnormal results remains challenging in an EHR-based integrated health care delivery system. Strategies improving provider EHR message box management and leveraging health information technology (eg, flagging abnormal eGFR results), making organizational/staffing changes (eg, increasing the role of nurses in managing laboratory results), and boosting patient engagement through better patient portals may improve test follow-up.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Danforth KN, Hahn EE, Slezak JM, et al. Follow-up of Abnormal Estimated GFR Results Within a Large Integrated Health Care Delivery System: A Mixed-Methods Study. Am J Kidney Dis. 2019. PMID: 31324445. doi:10.1053/j.ajkd.2019.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。